AN2 Therapeutics Inc (ANTX)
2.54
+0.15
(+6.28%)
USD |
NASDAQ |
May 02, 16:00
2.54
0.00 (0.00%)
After-Hours: 17:47
AN2 Therapeutics Total Assets (Quarterly): 138.74M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 138.74M |
| September 30, 2023 | 153.81M |
| June 30, 2023 | 98.93M |
| March 31, 2023 | 91.08M |
| December 31, 2022 | 102.56M |
| Date | Value |
|---|---|
| September 30, 2022 | 110.01M |
| June 30, 2022 | 120.02M |
| March 31, 2022 | 120.50M |
| December 31, 2021 | 65.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
65.32M
Minimum
Dec 2021
153.81M
Maximum
Sep 2023
111.22M
Average
110.01M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Gilead Sciences Inc | 56.29B |
| QuidelOrtho Corp | 8.563B |
| CymaBay Therapeutics Inc (DELISTED) | 434.69M |
| Insmed Inc | 1.330B |
| Revance Therapeutics Inc | 478.45M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.04M |
| Shareholders Equity (Quarterly) | 124.70M |